Artificial Intelligence in Pharma Forecasting
Whilst AI is amazing, it works well in some circumstances and poorly in others.
Inpharmation has looked carefully at the evidence for AI’s promise in forecasting and pricing (areas where we specialize).
Our latest book, The AI Cube, is a careful evidence-based review of what AI can and cannot do in forecasting and pricing pharmaceuticals.
At Inpharmation, we are making careful and reserved use of AI. But we are not in the business of hyping where evidence is lacking.
If you would like to see a considered review of what AI can do in forecasting and pricing, request a sample chapter of the book here…
The evidence for AI’s application in pharma pricing and forecasting is addressed in detail in the book The AI Cube: Can we use AI in pharma pricing and forecasting? by Inpharmation’s founder and chairman, Gary Johnson, and director of research and development, Sam Johnson.